NCT02453334 2021-05-11
IRON CLAD
American Regent, Inc.
Phase 3 Completed
Clinical Trials
3 trialsNCT01874561 2016-10-10
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization
Achieve Life Sciences
Phase 1 Completed
NCT00951574 2012-02-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Phase 3 Completed